Clinuvel Pharmaceuticals Limited (ASX:CUV)
Australia · Delayed Price · Currency is AUD 8.47
-0.71 (-7.73%)
Aug 28, 2026, 4:10 PM AEST
Clinuvel Pharmaceuticals Market Cap
Clinuvel Pharmaceuticals has a market cap or net worth of 427.12 million as of August 28, 2026. Its market cap has decreased by -37.11% in one year.
Market Cap
427.12M
Enterprise Value
177.01M
Revenue
94.02M
Ranking
n/a
PE Ratio
12.68
Stock Price
8.47
ChartMarket Cap Chart
Since February 13, 2001, Clinuvel Pharmaceuticals's market cap has increased from 5.23M to 427.12M, an increase of 8,073.58%. That is a compound annual growth rate of 18.81%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 427.12M | -31.71% |
| Dec 31, 2025 | 625.50M | 3.84% |
| Dec 31, 2024 | 602.36M | -24.90% |
| Dec 29, 2023 | 802.04M | -25.09% |
| Dec 30, 2022 | 1.07B | -20.36% |
| Dec 31, 2021 | 1.34B | 21.91% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Clarity Pharmaceuticals | 873.01M |
| Racura Oncology | 441.16M |
| Starpharma Holdings | 341.09M |
| Tetratherix | 341.02M |
| BLS Pharmaceuticals | 208.13M |
| Orthocell | 205.55M |
| Nyrada | 182.85M |
| Dimerix | 174.12M |